NDC 71894-110 - Zolgensma
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71894-110
- Package NDCs from labels
- 71894-110-01
- Manufacturer
- Novartis Innovative Technologies Inc.
- Effective date
- 2026-06-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Zolgensma - Novartis Innovative Technologies Inc. | Novartis Innovative Technologies Inc. | 2026-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 11.0 mL | 20000000000000 [arb'U] in 1mL | 14 |
| 71894-110-01 | Zolgensma | 5.5 mL in 1 VIAL | INJECTION, SUSPENSION | 5.5 mL | 20000000000000 [arb'U] in 1mL | 14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Physiolyte | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 19c04dcb-d6f2-4624-afd4-1c7b7ddcb85e | 2023-09-26 | Warnings, Adverse reactions | 02F3473H9O 451W47IQ8X |
| Allergies | APIS MELLIFICA, ECHINACEA, HYDRASTIS CANADENSIS, TARAXACUM OFFICINALE, ACONITUM NAPELLUS, AETHUSA CYNAPIUM, AGARICUS MUSCARIUS, ALETRIS FARINOSA, ALFALFA, ALLIUM CEPA, ALLIUM SATIVUM, AMBROSIA ARTEMISIAEFOLIA, ARSENICUM ALBUM, ARTEMISIA VULGARIS, ARUNDO MAURITANICA, AVENA SATIVA, BELLADONNA, BELLIS PERRENIS, BOVISTA, BROMIUM, BRYONIA, CAFFEINUM, CALCAREA CARBONICA, CALLUNA VULGARIS, FLOS, CAPSICUM ANNUUM, CAT HAIR, CHAMOMILLA, CHELIDONIUM MAJUS, CHENOPODIUM ANTHELMINTICUM, CINNAMOMUM | Newton Laboratories, Inc. | 0631d5e5-9da4-bcb7-e063-6394a90a62de | 2023-09-25 | Warnings | 451W47IQ8X |
| Epiforce P-HP | ARSENICUM ALBUM, BORAX, GRAPHITES, NATRUM MURIATICUM, SEPIA, SULPHUR | BioActive Nutritional, Inc. | 250441d1-e261-417e-9100-700368ea38fd | 2023-09-11 | Warnings | 451W47IQ8X |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | a9910e09-5aea-4ee1-a35e-ae4abf8b80b4 | 2023-09-07 | Warnings, Adverse reactions | 451W47IQ8X |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 023C2WHX2V 059QF0KO0R |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 059QF0KO0R ND2M416302 |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 059QF0KO0R ND2M416302 |
| AnubisMed | SODIUM BICARBONATE, ALOE BARBADENSIS LEAF JUICE, IMIDAZOLIDINYL UREA | ANUBIS COSMETICS SL | ebf4b3ab-34e1-185a-e053-2a95a90ace3a | 2023-09-05 | Warnings | 059QF0KO0R |
| MEB Puri-vega | MEB PURI-VEGA | Kadesh Incoporation Co,Ltd | 03865989-3034-10fc-e063-6394a90ac80b | 2023-09-05 | Warnings | 02F3473H9O |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE | ANUBIS COSMETICS SL | f22b212d-d21d-5984-e053-2995a90a683e | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 059QF0KO0R ND2M416302 |
| Anubis Barcelona Vital Line | HYDROLYZED ELASTIN, HYDROLYSED COLLAGEN, COCOGLYCERIDES | ANUBIS COSMETICS SL | ebe024f7-7c45-ad60-e053-2995a90a45d6 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Regul Oil | PROPYLENE GLYCOL, PANTHENOL, THIAMINE HCL | ANUBIS COSMETICS SL | eb8e5beb-4452-58c2-e053-2a95a90a66e0 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | 023C2WHX2V 059QF0KO0R |
| Anubis Barcelona Regul Oil | CETEARYL ETHYLHEXANOATE, PROPYLENE GLYCOL, GLYCERYL STEARATE SE | ANUBIS COSMETICS SL | eb68c3ab-7835-1a1c-e053-2995a90a0d66 | 2023-09-01 | Warnings | 059QF0KO0R ND2M416302 |
| Anubis Barcelona | PROPANEDIOL, GLYCERIN, MAGNESIUM ASCORBYL PHOSPHATE | ANUBIS COSMETICS SL | eb53cba1-0509-43bc-e053-2995a90a5e09 | 2023-09-01 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.